Synergic Effect of Novel WS2 Carriers Holding Spherical Cobalt Ferrite @cubic Fe3O4 (WS2/s-CoFe2O4@c-Fe3O4) Nanocomposites in Magnetic Resonance Imaging and Photothermal Therapy for Ocular Treatments and Investigation of Corneal Endothelial Cell Migration

Abstract

The design of novel materials to use simultaneously in an ocular system for driven therapeutics and wound healing is still challenging. Here, we produced nanocomposites of tungsten disulfide carriers with spherical cobalt ferrite nanoparticles (NPs) as core inside a cubic iron oxide NPs shell (WS2/s-CoFe2O4@c-Fe3O4). Transmission electron microscopy (TEM) confirmed that 10 nm s-CoFe2O4@c-Fe3O4 NPs were attached on the WS2 sheet surfaces. The cytotoxicity of the WS2 sheets and nanocomposites were evaluated on bovine cornea endothelial cells (BCECs) using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay for a duration of three days. The MTT assay results showed low toxicity of the WS2 sheets on BCECs by 67% cell viability at 100 μg/mL in 24 h, while the nanocomposites show 50% cell viability in the same conditions. The magnetic resonance imaging (MRI) of nanocomposites revealed the excellent T2-weighted imaging with an r2 contrast of 108 mM−1 S−1. The in vitro photothermal therapy based on WS2 sheets and WS2/s-CoFe2O4 @c-Fe3O4 nanocomposites using 808 nm laser showed that the maximum thermal energy dispatched in medium at different applied power densities (1200 mw, 1800, 2200, 2600 mW) was for 0.1 mg/mL of the sample solution. The migration assay of BCECs showed that the wound healing was approximately 20% slower for the cell exposed by nanocomposites compared with the control (no exposed BCECs). We believe that WS2/s-CoFe2O4@c-Fe3O4 nanocomposites have a synergic effect as photothermal therapy agents for eye diseases and could be a target in an ocular system using MRI.

Biocompatible Calcium Ion-Doped Magnesium Ferrite Nanoparticles as a New Family of Photothermal Therapeutic Materials for Cancer Treatment

“…Therefore, Ca 2+ -doped MgFe 2 O 4 NPs are excellent candidates for NIR-mediated PTT. The temperature change depended on the concentration, laser power density, and irradiation time [ 44 ].…”

Effects of Electromagnets on Bovine Corneal Endothelial Cells Treated with Dendrimer Functionalized Magnetic Nanoparticles

“…Moreover, the migration of the BCECs containing 1 μg/mL D-SPIONs was faster than that of the cells containing 10 μg/mL SPIONs ( Figure 5 ). Increases in nanoparticle agglomeration, cell uptake capacities, and nanoparticle moieties on the cell surfaces are the main reasons for the delay in cell migration under increases in the D-SPION concentration [ 37 ]. Under a magnetic field produced by electromagnets in tapping mode, wound closure in the BCECs treated with 1 μg/mL SPIONs took 10 h. This is even faster than wound closure in the control BCECs.…”

Ferrite-Supported Nanocomposite Polymers for Emerging Organic and Inorganic Pollutants Removal from Wastewater: A Review

“…226 The WS2/s-CoFe 2 O 4 @c-Fe 3 O 4 nanocomposites might be a target in an ocular system employing MRI due to their synergistic function as photothermal treatment agents for eye illnesses. 227 MRI-guided magnetotherapy chemotherapy using Gd-doped ferrite nanoparticles may improve therapeutic efficacy while reducing side effects. 228 A precise cancer diagnosis and treatment were made possible by the nanocomposite hydrogel's outstanding magnetic hyperthermia action, controlled release of drugs and nanospheres, and contrast in vivo MR imaging.…”

“…Fluorescence imaging and magnetic resonance imaging are two biological applications that might benefit from the fluorescence and magnetic characteristics of graphene quantum dots and cobalt ferrite nanocomposite . The WS2/s-CoFe 2 O 4 @c-Fe 3 O 4 nanocomposites might be a target in an ocular system employing MRI due to their synergistic function as photothermal treatment agents for eye illnesses . MRI-guided magnetotherapy chemotherapy using Gd-doped ferrite nanoparticles may improve therapeutic efficacy while reducing side effects .…”